ZERO Lauds Congress Passing Spending Package Maintaining Prostate Cancer Funding

Dec 18, 2015, 14:00 ET from ZERO - The End of Prostate Cancer

WASHINGTON, Dec. 18, 2015 /PRNewswire-USNewswire/ -- Earlier today, the Senate voted to send the Fiscal Year 2016 omnibus spending package to the President for signature.  The year-end bill provides $80 million for the Prostate Cancer Research Program (PCRP) at the Department of Defense and maintains funding for the Centers for Disease Control and Prevention's (CDC) prostate cancer activities, which had been targeted for elimination in the President's budget proposal to Congress.  The House passed the measure on Friday.

"The PCRP has produced significant advances for men battling prostate cancer, and we are very grateful to our Congressional champions for their leadership and commitment to biomedical research and the promise it holds for millions of families effected by this disease," said ZERO CEO Jamie Bearse.

ZERO – The End of Prostate Cancer commends the work of Senate Defense Appropriations Subcommittee Chairman Thad Cochran (R-MS) and Ranking Member Dick Durbin (D-IL) as well as House Appropriations Defense Subcommittee Chairman Rodney Frelinghuysen (R-NJ) and Ranking Member Pete Visclosky (D-IN). Their support and diligence in maintaining funding for the PCRP, along with the hard work of their staff, is critical for the men and families battling prostate cancer.

Without the hard work of Senators Mike Crapo (R-ID) and Bob Menendez (D-NJ) and Representatives Peter King (R-NY) and Sanford Bishop (D-GA), who led the effort to support the PCRP, this program could have been cut or eliminated.

ZERO lauds Labor-HHS-Education Appropriations Subcommittee Chairman Roy Blunt (R-MO) and Ranking Member Patty Murray (D-WA) for fighting off an ill-advised plan by the Office of Management and Budget to eliminate CDC prostate cancer activities funding.  The work the CDC does provides those in the public health and research communities with critical tools and communications pathways to ensure that men are making informed decisions about their treatment options.

The measure now moves to the White House, where President Obama is expected to sign it into law.

Logo -


SOURCE ZERO - The End of Prostate Cancer